UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                   FORM 10-QSB

                                   (Mark  One)
  [X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
                                     OF 1934

                  For the six month period ended June 30, 2000
                               ------------------

  [ ]  TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  EXCHANGE ACT

              For the period from ______________ to ______________

                        Commission file number    0-26445
                                     -------


                        ACCESS HEALTH ALTERNATIVES, INC.
                        --------------------------------
        (Exact name of small business issuer as specified in its charter)


                 Florida                             59-3542362
                 -------                             ----------
             (State of other jurisdiction            (IRS Employer
        of incorporation or organization)            Identification No.)


                 4619 Parkbreeze Court, Orlando, Florida  32808
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (407)  299-0629
                                 ---------------
                           (Issuer's Telephone Number)


--------------------------------------------------------------------------------
   (Former name, former address and former fiscal year, if changed since last
                                     report)



                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS


Check  whether  the  registrant  filed  all documents and reports required to be
filed  by  Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities  under  a  plan  confirmed  by  a  court.  Yes  [  ]  No  [  ]


                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity,  as of the latest practicable date.     2,661,509 shares of common stock
as  of  June  30,  2000.
                           --------------------------

Transitional  Small  Business  Disclosure  Format  (Check  one)  Yes [ ]  No [X]


<PAGE>
PART I - FINANCIAL INFORMATION


<TABLE>
<CAPTION>
                                ACCESS HEALTH ALTERNATIVES, INC.

                                   CONSOLIDATED BALANCE SHEET


                                                                     JUNE 30,     DECEMBER 31,
                                                                       2000           1999
                                ASSETS                              (UNAUDITED)     (AUDITED)
                                ------                             ------------  ------------
<S>                                                                <C>           <C>
Current assets:
  Cash                                                             $     2,242   $     1,757
  Receivables:
    Trade, net                                                          64,197        58,923
    Other                                                                4,380         4,380
                                                                   ------------  ------------
    Total receivables                                                   68,577        63,303
  Inventories                                                          121,170       144,250
                                                                   ------------  ------------

    Total current assets                                               191,989       209,310

Property and equipment, net                                             44,399        52,357
Other assets                                                             5,051         5,050
Deferred recission costs                                               640,663       640,663
                                                                   ------------  ------------

    Total assets                                                   $   882,102   $   907,380
                                                                   ============  ============



                See accompanying notes to consolidated financial statements


                                        1
<PAGE>
               LIABILITIES AND STOCKHOLDER'S DEFICIT
               -------------------------------------

Current liabilities:
  Notes Payable                                                    $ 1,573,851   $ 1,491,348
  Current obligation under capital lease                                 5,909         8,847
  Bank overdraft                                                         3,351         8,016
  Accounts payable                                                     476,376       404,935
  Accrued liabilities                                                  980,213       610,511
  Due to related parties:
    Stockholders                                                       183,086       185,137
    Limited liability companies including recision                   1,603,809     1,603,809
      of $763,750 to be offered to holders of economic
      interests at September 30, 1999
    Access Healthcare, Inc.                                             54,630        29,651
                                                                   ------------  ------------

        Total due to related parties                                 1,841,526     1,818,597
                                                                   ------------  ------------

        Total current liabilities                                    4,881,226     4,342,254

Unearned income                                                        235,370       274,370
Obligation under capital lease, less current portion                    10,749        10,749
Minority interest in subsidiary                                        129,545       129,545
                                                                   ------------  ------------

        Total liabilities                                            5,256,891     4,756,918

Stockholders' deficit:
  Preferred stock, $.01 par value, 10,000,000 shares authorized,             -             -
    none issued
  Common stock, $.001 par value, 50,000,000 shares authorized,
    2,661,509 shares issued and outstanding                              2,661         2,627
  Capital in excess of par value                                     1,530,183     1,530,217
  Accumulated deficit                                               (5,907,632)   (5,382,382)
                                                                   ------------  ------------

        Total stockholders' deficit                                 (4,374,788)   (3,849,538)
                                                                   ------------  ------------

        Total liabilities and stockholders' deficit                $   882,102   $   907,380
                                                                   ============  ============


                See accompanying notes to consolidated financial statements
</TABLE>


                                        2
<PAGE>
<TABLE>
<CAPTION>
                          ACCESS HEALTH ALTERNATIVES, INC.

                        CONSOLIDATED STATEMENT OF OPERATIONS

                                    (UNAUDITED)


                                        THREE MONTHS ENDED       SIX MONTHS ENDED
                                            JUNE 30,                 JUNE 30,
                                        2000        1999        2000        1999
                                     ----------  ----------  ----------  ----------
<S>                                  <C>         <C>         <C>         <C>
Revenues:
  Equipment                          $       -   $       -   $       -   $       -
  Products                              42,989     111,577      99,401     200,625
  Other                                 19,500     112,235      38,702     135,244
                                     ----------  ----------  ----------  ----------

    Total revenues                      62,489     223,812     138,104     335,869

Cost of sales:
  Equipment                                  -           -           -           -
  Products                               6,567      51,475      23,080      77,114
  Other                                      -       2,088           -       2,460
                                     ----------  ----------  ----------  ----------

      Total cost of sales                6,567      53,563      23,080      79,574
                                     ----------  ----------  ----------  ----------

      Gross profit                      55,922     170,249     115,023     256,295

Selling, general and administrative    175,695     273,971     589,763     707,739
                                     ----------  ----------  ----------  ----------

      Operating loss                  (119,773)   (103,722)   (474,740)   (451,444)

Other expense:
  Interest expense                      26,149      10,893      49,081      49,375
  Other, net                             1,381           -       1,431           -
                                     ----------  ----------  ----------  ----------

      Total other expense               27,529      10,893      50,512      49,375
                                     ----------  ----------  ----------  ----------

      Net loss                       $(147,302)  $(114,615)  $(525,251)  $(500,819)
                                     ==========  ==========  ==========  ==========

Basic net loss per share             $   (0.06)  $   (0.08)  $   (0.20)  $   (0.37)
                                     ==========  ==========  ==========  ==========


          See accompanying notes to consolidated financial statements
</TABLE>


                                        3
<PAGE>
<TABLE>
<CAPTION>
                                    ACCESS HEALTH ALTERNATIVES, INC.

                                  CONSOLIDATED STATEMENT OF CASH FLOWS

                                              (UNAUDITED)


                                                          THREE MONTHS ENDED       SIX MONTHS ENDED
                                                                JUNE 30,                JUNE 30,
                                                            2000        1999        2000        1999
                                                         ----------  ----------  ----------  ----------
<S>                                                      <C>         <C>         <C>         <C>
Cash flows from operating activities:
  Net loss                                               $(147,302)  $(114,615)  $(525,251)  $(500,819)
  Adjustment to reconcile net loss to net cash provided
    by (used in) operating activities:
      Depreciation and amortization                          3,979       9,749       7,958      18,347
      Losses of limited liability companies                      -      57,850           -      86,204
      Unearned income recognized                           (18,361)    (19,500)    (39,000)    (39,000)
      Issuance of common stock for services                      -     163,000           -     226,280
      Cash provided by (used in) changes in:
        Receivables                                         (6,212)    (18,311)     (5,274)    (21,250)
        Inventories                                          6,567      10,623      23,080      13,163
        Other assets                                             -      17,805           0     (10,906)
        Bank overdraft                                      (1,057)   (118,943)     (4,665)   (101,357)
        Accounts payable                                    46,044    (301,165)     71,441    (138,881)
        Accrued liabilities                                 96,005     (70,623)    369,702     (62,849)
                                                         ----------  ----------  ----------  ----------

        Net cash used in operating activities              (20,337)   (384,130)   (102,009)   (531,068)

Cash flows from investing activities:
  Purchases of property and equipment                            -      (3,556)         (0)     (7,938)
                                                         ----------  ----------  ----------  ----------

Cash flows from financing activities:
  Payments on Notes                                            913     (53,194)          -    (133,987)
  Proceeds from notes and commercial paper                  17,737     444,429      82,503     444,429
  Due to stockholders                                      (15,000)    (39,792)     (2,051)    (94,670)
  Advances (to) from limited liability companies                 -      61,479           -    (106,689)
  Due to related party                                      19,120       3,961      24,979         361
  Payments on capital lease obligations                     (1,303)          -      (2,938)          -
  Proceeds from issuance of stock                                -      25,000           -     510,000
                                                         ----------  ----------  ----------  ----------

        Net cash provided by financing activities           21,467     441,883     102,494     619,444
                                                         ----------  ----------  ----------  ----------

  Net (decrease) increase in cash                            1,130      54,197         485      80,438

    Cash at beginning of period                              1,112      26,660       1,757         419
                                                         ----------  ----------  ----------  ----------

    Cash at end of period                                $   2,242   $  80,857   $   2,242   $  80,857
                                                         ==========  ==========  ==========  ==========

Supplemental disclosure:
  Cash paid during the period for interest               $   4,895   $   3,353   $   9,410   $  36,482
                                                         ==========  ==========  ==========  ==========


                      See accompanying notes to consolidated financial statements
</TABLE>


                                        4
<PAGE>
                     ACCESS HEALTH ALTERNATIVES, INC.

                NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


(1)     ORGANIZATION

On  September  2,  1998, Access HealthMax Holdings, Inc. ("Holdings"), f/k/a PLC
Ventures  Corp.  ("PLC")  acquired approximately 94.3% of the outstanding common
stock of Access HealthMax, Inc. ("HealthMax"), for 565,100 shares of authorized,
but previously unissued common stock.  Immediately preceding the exchange, there
were 437,500 shares outstanding of PLC.  The shares of PLC had been issued for a
total consideration of $1,000.  PLC had no sales or revenues since its formation
on  October 2, 1988 and had zero stockholders' equity at the time of acquisition
of  HealthMax.  For  accounting purposes, the acquisition has been treated as an
acquisition  of  PLC  by  HealthMax  and  as  a  recapitilization  ("Reverse
Acquisition")  of  HealthMax.  The  historical  financial  statements  prior  to
September  2,  1998  are  those  of  HealthMax.  Pro  forma  information  is not
presented,  since  the  combination is a recapitilization rather than a business
combination.  The  deficiency  in  the  net  assets  of PLC were not adjusted in
connection  with the Reverse Acquisition since it consisted of accounts payable.

On March 11, 1999, Holdings changed its name to Access Health Alternatives, Inc.
("Alternatives").  Unless  the  context  indicates  otherwise,  references
hereinafter  to  the  "Company"  include  HealthMax  and/or  Alternatives.

On  March 3, 1999, the Board of Directors authorized a one-for-ten reverse stock
split  effective  March 15, 1999.  All references in the financial statements to
number  of  shares,  per share amounts and market prices of the Company's common
stock have been retroactively restated to reflect the decreased number of common
shares  outstanding.


(2)     BASIS  OF  PRESENTATION

In  the  opinion  of management, the accompanying unaudited interim consolidated
financial  statements  include  all  adjustments necessary to present fairly the
financial  position of the Company, the results of its operations and cash flows
for  the  interim periods reported.  These adjustments are of a normal recurring
nature.  However,  the  accompanying  unaudited  interim  consolidated financial
statements  have  been  prepared  in  accordance  with  the  instructions  and
requirements  of  Form  10-QSB and Regulation S-B and, therefore, do not include
all  information  and  footnotes  for a fair presentation of financial position,
results  of  operations  and  cash  flows  in conformity with generally accepted
accounting  principles.

The  balance  sheet  as  of  December  31,  1999,  was  derived from the audited
consolidated balance sheet.  These statements should be read in conjunction with
the  financial  statements  included in the Company's Form 10-KSB filed with the
Securities  and  Exchange Commission, which include audited financial statements
for  the year ended December 31, 1999. The results of operations for the interim
periods  presented  are  not  necessarily  indicative of the results that may be
expected  for  the  year.


                                        5
<PAGE>
                     ACCESS HEALTH ALTERNATIVES, INC.

                NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


(3)     LITIGATION

In  October,  1999  HealthMax  was advised by the Department of Professional and
Financial  Regulation,  Bureau  of Banking, Securities Division for the State of
Maine that certain sales of LLC's economic interests to Maine residents were not
covered by an exemption from registration, and were effected with the assistance
of  a  person  not  licensed to sell securities in that state, and therefore are
subject  to  rescission  to  the Maine investors, but has not yet determined the
manner  or  method  of this offer.  Neither the LLC's, HealthMax nor the Company
has sufficient funds available to return the full amount of the Maine investors'
interests  ($763,750),  should  they all elect to rescind their investment.  The
Company  has  recorded a liability previously recorded with respect to the state
of  Maine  investors  of $640,663.  The Company has recorded deferred rescission
costs  for  $640,663.

In  December  1999,  the Company became aware of an inquiry by the Comptroller's
office  of  the  State of Florida into the manner by which certain LLC interests
were  sold  to  residents of Florida.  The State has requested certain documents
and  information  from  the  Company,  from LLC's and from HealthMax in what the
Company  believes  is  an  effort  to  determine if securities were sold without
registration  or  without  an  exemption  from  registration,  or by persons not
licensed  to  sell securities in the State.  The Company is cooperating with the
State's  inquiry,  and  is unable to speculate at this time as to the outcome of
such  inquiry.  All LLC interests sold in the State of Florida are approximately
$1,472,000.

The Company has been notified of three separate law suits by various lenders and
vendors  demanding, among other things, return of principle and interest.  There
has  also  been  a  suit  filed  by  one  LLC  investor.


(4)     CONTINGENCY

At  December  31,  1999, the Company has suffered recurring losses and has a net
capital deficiency of $3,849,538 and a working capital deficiency of $4,132,944,
which raises substantial doubt about its ability to continue as a going concern.
Such  losses have continued through 2000.  The Company is contemplating a public
or  private  offering  of securities and/or the borrowing of funds as a means of
raising  capital  to  implement its business plan.  Management of the Company is
considering,  and has consulted with its attorneys as to, the possibility of the
Company's filing for protection under the federal bankruptcy laws if an offering
of  securities  and/or  the  borrowing  of funds cannot be accomplished within a
reasonable  time.


                                        6
<PAGE>
                     ACCESS HEALTH ALTERNATIVES, INC.

                NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


(5)     SUBSEQUENT  EVENTS

ACCESS  HEATHCARE
The  Company agreed to acquire Access HealthCare, Inc. (Healthcare) during 1999,
subject  to  certain  conditions including the financing of Alternatives.  Under
the terms of the acquisition, to be accounted for as a pooling of interests, the
Company  will exchange approximately 2,000,000 shares of common stock for all of
HealthCare's  outstanding  shares.  HealthCare  operates  a  chiropractic  group
practice in Central Florida and has affiliated chiropractic practices throughout
Florida.

If  the  acquisition  is  consummated,  the  financial  position  and results of
operations of the Company and HealthCare will be combined in 2000 retroactive to
January  1,  2000.  In addition, all prior periods presented will be restated to
give  effect  to  the  pooling.

Presented  below are condensed combined pro forma financial statements as of and
for  the six month period ended June 30, 2000 to give effect to the transaction.
The  condensed  combined  financial  statements  reflect  the  elimination  of
intercompany  transactions.

     Condensed  balance  sheet  at  June  30,  2000:

<TABLE>
<CAPTION>
                                       COMPANY     HEALTHCARE   ELIMINATIONS     COMBINED
                                     ------------  -----------  -------------  ------------
<S>                                  <C>           <C>          <C>            <C>
Assets:
   Current assets                    $   191,989      341,445              -       533,434
   Property & equipment, net              44,399       68,604              -       113,003
   Other assets                            5,051       48,630        (48,419)        5,262
   Deferred rescission costs             640,663            -              -       640,663
                                     ------------  -----------  -------------  ------------
                                     $   882,102      458,679        (35,510)    1,292,362
                                     ============  ===========  =============  ============

Liabilities:
   Current liabilities               $ 4,881,226      499,577        (48,419)    5,332,384
   Unearned income                       235,370            -              -       235,370
   Long-term obligations                  10,750      116,069              -       126,819
   Minority interest                     129,545            -              -       129,545
                                     ------------  -----------  -------------  ------------
                                       5,256,891      615,646        (48,419)    5,824,118
   Stockholders' deficit              (4,374,789)    (156,967)             -    (4,531,756)
                                     ------------  -----------  -------------  ------------
                                     $   882,102      458,679        (48,419)    1,292,362
                                     ============  ===========  =============  ============


                                        7
<PAGE>
                           ACCESS HEALTH ALTERNATIVES, INC.

                       NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



                                       COMPANY     HEALTHCARE   ELIMINATIONS     COMBINED
                                     ------------  -----------  -------------  ------------
Condensed statement of operations:
Revenues                             $   138,104    1,208,247        (22,541)    1,323,809

Operating costs and expenses             612,843    1,042,400        (22,541)    1,632,703
                                     ------------  -----------  -------------  ------------
Operating income (loss)                 (474,740)     165,846              -      (308,893)
Other expenses                           (50,512)     (27,067)             -       (77,579)
                                     ------------  -----------  -------------  ------------
Net income (loss)                    $  (525,251)     138,779              -      (386,472)
                                    =============  ===========  =============  ============

Basic net loss per share                                                       $      (.15)
                                                                               =============
</TABLE>


                                        8
<PAGE>
ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION.

     The  following  discussion  and analysis should be read in conjunction with
the  financial  statements  of  the Company and the accompanying notes appearing
previously  under  the  caption "Financial Statements." The following discussion
and  analysis  contains  forward-looking  statements,  which  involve  risks and
uncertainties.  The  Company's  actual results may differ significantly from the
results,  expectations  and plans discussed in these forward-looking statements.

Results  of  Operations  for the Period Ended June 30, 2000 compared with Period
Ended  June  30,  1999:

     Management  believes  that a comparison of the financial performance of the
Company  in  the six months ended June 30, 2000 and in the six months ended June
30,  1999 clearly shows the continued impact of a lack of capital as well as the
change  in  its approach to the marketplace.  In  addition the capital shortfall
has  consumed  the  attention  of Senior Management as they established a public
trading  market  for  the  Company's  securities.

     During  the  six months represented, the Company continued to down size its
operations  and  reduce  overhead  in  order  to accommodate the cash shortfall.
Certain  operations  and  development activities were suspended unless and until
new  capital is raised.  The resulting impact to Total Revenues was a decline of
58.9%  dropping to $138,104.  This Revenue figure is expected to decline further
in  the third quarter but will soon reach a base representing core ongoing sales
of  the  products.  Marketing  activities  during the six months revolved around
limited  direct  mail  to  current and past customers and promotions of specific
products.  There  has  been  a  decline  in the provider network as all regional
sales  and  support  activities were suspended other than in the Central Florida
market.  Sales  and support activity is currently being handled by the corporate
staff  in  Orlando.

     Selling,  general  and  administrative  expenses  declined  16.7%  and  are
expected  to  further  decline  in  the  third  quarter.

Liquidity  and  Capital  Resources

     Continued cash flow shortages have slowed the Company's growth and diverted
management's  attention  away  from  development  activities.  The  Company  has
experienced  a rise in accounts payable and accrued liabilities.  They increased
from  $1,015,446  at  the  beginning  of  the year to $1,456,589, or 43.4%, when
combined,  and  from  $1,314,541  at  the  beginning of the quarter or 9.8%. The
Company  continues  to rely on loans from affiliated and unaffiliated parties to
cover  some of its cash flow shortfall.  As evidence, Notes Payable increased by
$18,650  for  the second quarter to $1,573,851. Loans from Access Healthcare, an
announced  acquisition,  increased  to  $54,630.

     Accounts  receivable  and  other  current  and  long-term  assets  remained
relatively  unchanged other then a reduction in Inventory of $23,080 for the six
months and $6,567 for the second quarter to $121,170 reflecting sales during the
period(s).  Total  asset decline of $25,278 for the six months and of $3,205 for
the  second  quarter  to $882,102 is explained by the reduction in Inventory and
depreciation of property and equipment.  There were no purchases or disposals of
assets  during  the  period(s)  other  than  in  the  normal course of business.

     The cash used in operations for the six months ended June 31, 2000 and 1999
was  $102,009  and  $531,068,  respectively.


                                        9
<PAGE>
     The Company continues to experience negative cash flow and anticipates this
continuing through the end of the current fiscal year.  Management believes that
additional  funding  will  be  necessary  in order for it to continue as a going
concern.  Several  options  are  being  actively  pursued  including the private
placement  of  Preferred  stock  and a possible secondary public offering of the
Companies  Common  stock , as well as the borrowing of funds.  Management of the
Company  is  considering,  and  has  consulted  with  its  attorneys  as to, the
possibility  of the Company's filing for protection under the federal bankruptcy
laws  if  an  offering  of  securities  and/or  the borrowing of funds cannot be
accomplished  within  a  reasonable  time.


                           PART  II  -  OTHER  INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS.

     Access  HealthMax,  Inc.  has  been  named in two suits.  Innovative Health
Products,  Inc.  has  alleged  non-payment  and is demanding, among other things
payment of all  amounts owed.  Management believes any financial outcome as been
fully  reserved for and reflected in the statements.  In addition, suit has been
brought  by  Raymond  J. Rousseau and Theresa Rousseau against Access HealthMax,
Inc.  and others, it has not been determined what impact a judgement against the
company would have other then repayment of financial investment of $75,000 by an
LLC  of  which  Access  HealthMax is the managing partner.  Two other actions by
lenders,  previously  disclosed,  remain  pending.


ITEM  2.  CHANGES  IN  SECURITIES

     In  April  2000,  the  Company designated the rights and preferences of its
Series  B  Redeemable Convertible Preferred Stock, and authorized the sale of up
to  2,800,000 common shares as part of the offering. To date no shares have been
sold.

     In  January 2000, the Company issued 100,000 shares each to Donald Metchick
and  Steven Miracle pursuant to their respective Employment Agreements, pursuant
to  Section  4(2)  of  the  Securities  and  Exchange  Act  of  1933.

     In  July  2000,  pursuant  to an agreement made in 1999, the Company issued
34,722  shares  of common along with two sets of warrants, each set allowing the
investor  to  purchase  up  to 34,722 shares of common with an exercise price of
$3.00  and $4.50.  The shares and warrants were sold pursuant to Section 4(2) of
the  Securities  and  Exchange  Act  of  1933.

     In  July  2000,  a minority investor in Access HealthMax, Inc.converted his
interest  into  20,000  shares of Access Health Alternatives, IncThe shares were
converted  pursuant  to Section 4(2) of the Securities and Exchange Act of 1933.

ITEM  3.  DEFAULTS  UPON  SENIOR  SECURITIES

Access HealthMax, Inc. continues to be in default of is loan agreements and will
be  unable  to  pay  interest  and  principle until new capital has been raised.

ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS

none

ITEM  5.  OTHER  INFORMATION.

     In  April  2000,  the  Company  received confirmation that its registration
statement on Form 10SB under the Securities Exchange Act of 1934  (the "Exchange
Act")  had "cleared" comments.  Subsequently the companies common stock regained
listing  on  the  Over  the  Counter  Bulletin  Board.


                                       10
<PAGE>
     In  April  2000,  the  Company,  and Vitacare Solutions, Inc. ("Vitacare"),
agreed  to  merge in an all stock transaction.  The merger was contingent of due
diligence  and  definitive  documents.  On  June  30,  2000 the company informed
Vitacare  that  it would not be going forward with the merger as planned.  There
have  been  no  further  conversation  between  the  Company  and  Vitacare.


ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K

n/a

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the Company caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.


                                   ACCESS  HEALTH  ALTERNATIVES,  INC.
                                   -----------------------------------
                                              (registrant)



     Date:   8/11/00                      /s/  Daniel  J.  Pavlik
            --------                     ---------------------------------------
                                                       (signature)*
                                         Daniel  J.  Pavlik,  President  &  CEO



     Date:   8/11/00                      /s/  Steven  Miracle
            --------                     ---------------------------------------
                                                       (signature)*
                                         Steven Miracle, Chief Operating Officer


*Print  the  name  and  title  of  each  signing  officer  under this signature.


                                       12
<PAGE>